| Test Name | Description | CPT/HCPCS Codes | Price* | Cash Price/Cost1 |
| SARS-CoV-2 RNA (COVID-19), Qualitative NAAT2 | The test is designed to detect the virus that causes COVID-19 in respiratory specimens, for example nasal or oral swabs. | U0003 (1) | Quest will bill your health plan or the government $100.003, 4 | Zero out-of pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider1 |
| SARS-CoV-2 Antibody (IgG), Spike, SemiQuantitative test | This test may detect an immune response to a prior or recent infection with SARS-CoV-2 (COVID-19). | 86769 | Quest will bill your health plan or the government $55.003 | Zero out-of pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider1 |
| SARS-CoV-2 Serology (COVID-19) Antibodies (IgG, IgM), Immunoassay | The test is designed to detect IgG and IgM antibodies in a blood sample that may indicate exposure to SARS-CoV-2 (COVID-19). IgM antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, with IgG antibodies typically reaching detectable levels simultaneously or 1-2 days later. | 86769 x2 | Quest will bill your health plan $110.003 | Zero out-of pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider1 |
| SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT | This is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B. | 87636 (1) | Quest will bill your health plan $511.703 | Zero out-of pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider1 |
| COVID-19 Active Infection | QuestDirect | The test is designed to detect the virus that causes COVID-19 in respiratory specimens. This test is for individuals who decide to pay out of pocket for the test and do not wish to have their claims submitted for reimbursement to their health plan or the government. | NA | Total Patient Cash Price/Cost: $128.30*
*Pricing is comprised of $119.00 for testing and conveyance of results, plus $9.30 for electronic order review by an authorized 3rd party provider | $128.30 |
| COVID-19 Antibody Test | QuestDirect | The test is designed to detect antibodies in a blood sample that would indicate that a patient may have prior or recent COVID-19 infection. This test is for individuals who decide to pay out of pocket for the test and do not wish to have their claims submitted for reimbursement to their health plan or the government. | NA | Total Patient Cash Price/Cost: $128.30*
*Pricing is comprised of $119.00 for testing and conveyance of results, plus $9.30 for independent physician oversight of lab testing including ordering testing if appropriate, and providing physician follow-up services. | $128.30 |
